Lymphoma Steering Committee
The NCI Lymphoma Steering Committee (LYSC) was established in 2009.
The LYSC follows an efficient, cost-effective, science-driven, and transparent process to identify and promote the "Best Science" in clinical research on lymphoma and related diseases by addressing the design and prioritization of phase 3 trials and large phase 2 studies.
Clinical Trials Planning Meetings (CTPMs)
- Lymphoma – November 2014
- B-Cell Lymphoma (DLBCL) Working Group – October 2010
- Executive Summary
CCCT Contact: Lawrence Baizer, Ph.D.